NIH study finds that failing to account for mixed genetic lineages could lead to inaccuracies.

Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias.

New study in Science Advances.

The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation...

New product.

Rutgers professor chairs panel to determine new recommendations for red blood cell transfusions.

Neonatal research applications have been identified as a focus area.

PGx can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind rather than guessing what may work best under...

Doctors may be able to target these genes with existing medications – or possibly even nutritional supplements – to slow or halt the disease’s progression.

New findings offer fresh glimpse of APOE, scores of new molecular players in the central nervous system.